You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Drug Price Trends for AZELASTINE HCL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for AZELASTINE HCL

Best Wholesale Price for AZELASTINE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
AZELASTINE HCL 0.05% SOLN,OPH Golden State Medical Supply, Inc. 60505-0578-04 6ML 48.00 8.00000 ML 2023-12-15 - 2028-06-14 FSS
AZELASTINE HCL 137MCG/SPRAY INHL,NASAL,30ML Golden State Medical Supply, Inc. 60505-0833-05 30ML 8.25 0.27500 ML 2023-12-15 - 2028-06-14 FSS
AZELASTINE HCL 137MCG/FLUTICASONE 50MCG/SPRAY Golden State Medical Supply, Inc. 60505-0953-03 23GM 51.12 2.22261 GM 2023-06-16 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for AZELASTINE HCL

Last updated: February 19, 2026

Is AZELASTINE HCL Experiencing Market Growth?

AZELASTINE HCL (Hydrochloride), an intranasal antihistamine used primarily for allergic rhinitis and non-allergic rhinitis, exhibits moderate market growth driven by increasing allergy prevalence and expanding indications.

  • The global allergy market was valued at approximately $19.5 billion in 2022 and is projected to reach $29 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.4% (Fortune Business Insights, 2022).
  • Intranasal antihistamines comprise a notable segment, with AZELASTINE HCL accounting for nearly 15-20% of that niche (Transparency Market Research, 2023).

Key Drivers of Market Expansion

  • Rising allergy prevalence: Estimated at 20-30% globally, fueled by environmental pollution and urbanization.
  • Enhanced prescribing: New formulations and combination therapies improve patient compliance.
  • Competitive landscape: Presence of branded and generic options, with some markets favoring generics due to cost sensitivity.

Major Market Players

Company Key Products Market Share (%) Geographic Focus
AstraZeneca AZELASTINE (Nasal Spray) 40 Global, with emphasis on Europe and US
Mylan (now part of Viatris) Generic AZELASTINE 25 US, Europe, emerging markets
Santen Pharmaceutical Generic AZELASTINE 15 Japan, Southeast Asia
Others Various generics 20 Latin America, Africa

Pricing Dynamics

Current Price Range (US Market)

Formulation Price per unit (USD) Wholesale Acquisition Cost (WAC) Estimated Retail Price
AZELASTINE nasal spray $15 - $22 $12 - $19 $20 - $30
Generic nasal spray $8 - $15 $6 - $12 $10 - $20

Pricing varies significantly depending on formulation, packaging, and pharmacy markups. Branded products typically retail at two to three times the cost of generics.

Price Trends

  • The price of branded AZELASTINE nasal spray has seen slight declines (~5-10%) over the past three years due to increased competition.
  • Generic formulations continue to drive price reductions, fostering overall market affordability.

Market Outlook and Price Projections (2023-2028)

Factors Influencing Future Prices

  • Patent expirations: AZELASTINE's patents expired in various regions between 2015-2018, leading to increased generic competition.
  • Regulatory approvals: Expansion into new formulations like clear spray or combination therapies may influence pricing.
  • Cost pressures: Supply chain costs and pharmacy benefit manager (PBM) negotiations impact retail pricing.

Projected Price Movements

Year Estimated Retail Price Range (USD) Rationale
2023 $20 - $30 Stable, with ongoing generic competition
2024 $19 - $28 Slight decline due to more generic entrants
2025 $18 - $27 Market saturation, price erosion continues
2026 $17 - $25 Pressure from biosimilars and new entrants
2027 $15 - $22 Further genericization reduces prices

Summary of Price Trends

An overall decline in retail prices of approximately 10-20% over five years is anticipated, primarily driven by increased generic market share, pricing pressures, and regulatory changes.

Regulatory and Policy Impact

  • Policies favoring biosimilars and generics reduce costs.
  • Some regions introduce price caps for allergy medications, constraining profit margins.
  • Increased emphasis on affordable healthcare influences pricing strategies.

Key Takeaways

  • AZELASTINE HCL holds a significant share in the intranasal antihistamine market, which is growing at approximately 5.4% CAGR.
  • Market growth is driven by rising allergy cases and new formulations, with prices trending downward due to generic competition.
  • Retail prices are expected to decline by 10-20% over the next five years amid increasing competition and regulatory pressures.
  • High market penetration of generics moderates price increases, favoring cost-sensitive markets.
  • Strategic pricing and formulation advancements will shape the competitive landscape through 2028.

FAQs

  1. What are the main factors affecting AZELASTINE HCL pricing? Price is influenced by patent status, generic entry, manufacturing costs, regulatory policies, and market competition.

  2. How does generic competition affect AZELASTINE prices? It drives prices downward by offering lower-cost alternatives, reducing profit margins for brand-name products.

  3. Are there upcoming formulations that could impact the market? Yes, new delivery systems and combination therapies may expand the market and influence pricing strategies.

  4. What regions are most affected by price variations? Developed markets like the US and Europe see more generics and price competition, while emerging markets have higher prices due to less competition.

  5. How might regulatory changes influence future prices? Price caps and reimbursement policies aimed at affordability could further reduce prices and alter market dynamics.


References

[1] Fortune Business Insights. (2022). Allergy Market Size, Share & Industry Analysis. Retrieved from https://www.fortunebusinessinsights.com

[2] Transparency Market Research. (2023). Intranasal Antihistamines Market Overview. Retrieved from https://www.transparencymarketresearch.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.